Showing results (91-100 of 138) with videos related to

Sort By:
Pageof 14
Molecular and Biochemical Parasitology|July 11, 2002
The architecture of variant surface glycoprotein gene expression sites in Trypanosoma bruceiMatthew Berriman, Neil Hall, Karen Sheader, et al.
Nucleic Acids Research|March 19, 2011
The structural basis for recognition of base J containing DNA by a novel DNA binding domain in JBP1Tatjana Heidebrecht, Evangelos Christodoulou, Michael J Chalmers, et al.
Nucleic Acids Research|February 10, 2015
Defining the sequence requirements for the positioning of base J in DNA using SMRT sequencingPaul-Andre Genest, Loren Baugh, Alex Taipale, et al.
The FEBS Journal|January 19, 2007
cGMP transport by vesicles from human and mouse erythrocytesCornelia J F de Wolf, Hiroaki Yamaguchi, Ingrid van der Heijden, et al.
Cancer Research|February 11, 2010
Sensitivity and acquired resistance of BRCA1;p53-deficient mouse mammary tumors to the topoisomerase I inhibitor topotecanSerge A L Zander, Ariena Kersbergen, Eline van der Burg, et al.
Cell Reports|December 3, 2014
Parallel in vivo and in vitro melanoma RNAi dropout screens reveal synthetic lethality between hypoxia and DNA damage response inhibitionPatricia A Possik, Judith Müller, Carmen Gerlach, et al.
Cell|May 20, 2008
Large-scale mutagenesis in p19(ARF)- and p53-deficient mice identifies cancer genes and their collaborative networksAnthony G Uren, Jaap Kool, Konstantin Matentzoglu, et al.
Molecular Pharmacology|October 13, 2006
The effect of low pH on breast cancer resistance protein (ABCG2)-mediated transport of methotrexate, 7-hydroxymethotrexate, methotrexate diglutamate, folic acid, mitoxantrone, topotecan, and resveratrol in in vitro drug transport modelsPauline Breedveld, Dick Pluim, Greta Cipriani, et al.
Nature Methods|December 20, 2017
BRCA-deficient mouse mammary tumor organoids to study cancer-drug resistanceAlexandra A Duarte, Ewa Gogola, Norman Sachs, et al.
Cancer Research|May 19, 2005
The human multidrug resistance protein MRP5 transports folates and can mediate cellular resistance against antifolatesPeter Wielinga, Jan Hendrik Hooijberg, Sjofn Gunnarsdottir, et al.
Pageof 14